Clotting (DBCOND0022770)
Identifiers
- Synonyms
- Clot / Thrombus / Clot blood / Blood clot (morphologic abnormality) / Coagulation defect, unspecified / Disorder of hemostatic system (disorder) / Disorder coagulation / Coagulation disorder / Defect coagulation (NOS) / Blood coagulation disorder (disorder) / Blood Coagulation Disorders / Clotting disorder / Coagulopathies / Coagulopathy / Coagulation disorder NOS
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Dalteparin A low molecular weight heparin used for the prophylaxis of thrombotic events in certain patients and prevent acute cardiac ischemic events in patients with unstable angina and non-Q-wave myocardial infarction.- Vascular endothelial growth factor A, long formtarget
- Heparanaseenzyme
- Antithrombin-IIItarget
- P-selectintarget
Heparin An anticoagulant indicated for thromboprophylaxis and to treat thrombosis associated with a variety of conditions such as pulmonary embolism and atrial fibrillation.- Antithrombin-IIItarget
- Coagulation factor Xtarget
- P-selectintarget
- Heparanaseenzyme
- Fibroblast growth factor receptor 4target
- Fibroblast growth factor 4target
- Fibroblast growth factor 19target
- Fibroblast growth factor receptor 1target
- Fibroblast growth factor 1target
- Fibroblast growth factor receptor 2target
- Fibroblast growth factor 2target
- Platelet factor 4target
- Hepatocyte growth factortarget
Nadroparin A low molecular weight heparin used for the prophylaxis of thrombotic events and deep vein thrombosis, and prevent unstable angina and non-Q-wave myocardial infarction.- Protein c-Fostarget
- Myc proto-oncogene proteintarget
- P-selectintarget
- Antithrombin-IIItarget
Tinzaparin A low molecular weight heparin used for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin.- Clinical Trials
- Not Available